In addition, EVs from HNSCC tumors frequently carry DNA repair enzymes such as ERCC1 and XRCC1, enabling recipient cells to better withstand platinum-based chemotherapy (15, 25, 26). The gene discussed is XRCC1; the disease is head and neck squamous cell carcinoma.